Email UpdatesLiterature Collection
Collection Insights
11K+
References
9K+
Articles
1400+
Grey Literature
4600+
Opioids & SU
The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More
Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).
11199 Results
9842
The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders
Type: Journal Article
Year: 2015
Publication Place: England
Topic(s):
Opioids & Substance Use
See topic collection
Reference Links: 
View the DOI record for The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders
View DOI Record
View the PubMed citation for The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders9843
The Impact of Alternative Payment in Chronically Ill and Older Patients in the Patient-centered Medical Home
Type: Journal Article
Year: 2017
Publication Place: United States
Abstract: BACKGROUND: Patient-centered medical home (PCMH) has gained prominence as a promising model to encourage improved primary care delivery. There is a paucity of studies that evaluate the impact of payment models in the PCMH. OBJECTIVES: We sought to examine whether coupling coordinated, team-based care transformation plan with a novel reimbursement model affects outcomes related to expenditures and utilization. RESEARCH DESIGN: Interrupted time-series model with a difference-in-differences approach to assess differences between intervention and control groups, across time periods attributable to PCMH transformation and/or payment change. RESULTS: Although results were modest and mixed overall, PCMH with payment reform is associated with a reduction of $1.04 (P=0.0347) per member per month (PMPM) in pharmacy expenditures. Patients with hypertension, hyperlipidemia, diabetes, and coronary atherosclerosis enrolled in PCMH without payment reform experienced reductions in emergency department visits of 2.16 (P<0.0001), 2.42 (P<0.0001), 3.98 (P<0.0001), and 3.61 (P<0.0001) per 1000 per month. Modest increases in inpatient admission were seen among these patients in PCMH either with or without payment reform. Patients 65 and older enrolled in PMCH without payment reform experienced reductions in pharmacy expenditures $2.35 (P=0.0077) PMPM with a parallel reduction in pharmacy standardized cost of $2.81 (P=0.0174) PMPM indicative of a reduction in the intensity of drug utilization. CONCLUSIONS: We conclude that PCMH implementation coupled with an innovative payment arrangement generated mixed results with modest improvements with respect to pharmacy expenditures, but no overall financial improvement. However, we did see improvement within specific groups, especially older patients and those with chronic conditions.
Topic(s):
Financing & Sustainability
See topic collection
, Medical Home
See topic collection
Reference Links:
View the DOI record for The Impact of Alternative Payment in Chronically Ill and Older Patients in the Patient-centered Medical Home
View DOI Record
View the PubMed citation for The Impact of Alternative Payment in Chronically Ill and Older Patients in the Patient-centered Medical Home9846
The impact of Assertive Community Treatment on utilization of primary care and other outpatient health services: the North Carolina experience
Type: Journal Article
Year: 2013
Publication Place: United States
Abstract: BACKGROUND: A number of states have implemented Assertive Community Treatment (ACT) teams statewide. The extent to which team-based care in ACT programs substitutes or complements primary care and other types of health services is relatively unknown outside of clinical trials. OBJECTIVE: To analyze whether investments in ACT yield savings in primary care and other outpatient health services. DESIGN: Patterns of medical and mental health service use and costs were examined using Medicaid claims files from 2000 to 2002 in North Carolina. Two-part models and negative binomial models compared individuals on ACT (n = 1,065 distinct individuals) with two control groups of Medicaid enrollees with severe mental illness not receiving ACT services (n = 1,426 and n = 41,717 distinct individuals). RESULTS: We found no evidence that ACT affected utilization of other outpatient health services or primary care; however, ACT was associated with a decrease in other outpatient health expenditures (excluding ACT) through a reduction in the intensity with which these services were used. Consistent with prior literature, ACT also decreased the likelihood of emergency room visits and inpatient psychiatric stays. CONCLUSIONS: Given the increasing emphasis and efforts toward integrating physical health and behavioral health care, it is likely that ACT will continue to be challenged to meet the physical health needs of its consumers. To improve primary care receipt, this may mean a departure from traditional staffing patterns (e.g., the addition of a primary care doctor and nurse) and expansion of the direct services ACT provides to incorporate physical health treatments.
Topic(s):
Education & Workforce
See topic collection
, Financing & Sustainability
See topic collection
9847
The impact of behavioral health consultations on medical encounter duration in pediatric primary care: A retrospective match-controlled study
Type: Journal Article
Year: 2019
Publication Place: United States
Topic(s):
General Literature
See topic collection
9849
The Impact of Brief Interventions on Functioning Among those Demonstrating Anxiety, Depressive, and Adjustment Disorder Symptoms in Primary Care: The Effectiveness of the Primary Care Behavioral Health (PCBH) Model
Type: Journal Article
Year: 2022
Topic(s):
Education & Workforce
See topic collection
9850
The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone
Type: Journal Article
Year: 2012
Publication Place: Ireland
Topic(s):
Opioids & Substance Use
See topic collection
, Healthcare Disparities
See topic collection
9851
The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada
Type: Journal Article
Year: 2017
Publication Place: Netherlands
Topic(s):
Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada
View DOI Record
View the PubMed citation for The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada9852
The impact of cognitive challenges in major depression: the role of the primary care physician
Type: Journal Article
Year: 2016
Publication Place: England
Abstract: Nearly 1 in 5 Americans will struggle with major depression in their lives; some will have recurring bouts. Recent psychiatric research has given new attention to the prevalence of cognitive deficits in major depression and the impact such deficits have on remission and overall life functioning. When depression is partially treated i.e., leaving residual symptoms, patients have higher rates of relapse and lower functional outcomes. Impaired cognitive functioning is a frequent residual symptom, persisting in about 45% of patients even when emotional symptoms have improved, and results in a disproportionate share of the functional impairment, particularly in the workplace. Patients with depression have disrupted circuitry in brain regions responsible for cognition and it is therefore important to screen depressed patients for cognitive as well as emotional symptoms. Cognitive dysfunction should be evaluated in every mood disordered patient with validated self-report scales such as the Patient Health Questionnaire-9 or the Beck Depression Inventory and objective measures of cognitive function are also very very useful. Two easily administered tests are the Trails B Test and the Digit Symbol Substitution Test. Each take less than two minutes and measure working memory, executive function, and processing speed and can track cognitive improvement in depressed patients. Treatment of cognitive dysfunction in major depression is complicated by the 'serotonin conundrum': SSRI's frequently do not treat to full remission, and can cause cognitive blunting-actually adding to cognitive problems. Based on recent data including results from a recently completed meta-analysis by McIntyre and colleagues, an evidence-based algorithm for treating cognitive symptoms in depression is presented. A hierarchy of antidepressants and augmentation strategies based on the best available evidence is discussed. In conclusion, cognitive symptoms in major depressive disorder have been recognized as a target of therapeutic improvement by the FDA and have become a focus of clinical importance.
Topic(s):
General Literature
See topic collection
Reference Links:
View the DOI record for The impact of cognitive challenges in major depression: the role of the primary care physician
View DOI Record
View the PubMed citation for The impact of cognitive challenges in major depression: the role of the primary care physician9855
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review
Type: Journal Article
Year: 2021
Topic(s):
Education & Workforce
See topic collection
, Financing & Sustainability
See topic collection
, Healthcare Disparities
See topic collection
, Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review
View DOI Record
View the PubMed citation for The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review9856
The impact of COVID-19 on opioid treatment programs in the United States
Type: Journal Article
Year: 2021
Topic(s):
Education & Workforce
See topic collection
, Financing & Sustainability
See topic collection
, HIT & Telehealth
See topic collection
, Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for The impact of COVID-19 on opioid treatment programs in the United States
View DOI Record
View the PubMed citation for The impact of COVID-19 on opioid treatment programs in the United States9858
The Impact of Early Substance Use Disorder Treatment Response on Treatment Outcomes Among Pregnant Women With Primary Opioid Use
Type: Journal Article
Year: 2018
Publication Place: United States
Abstract: OBJECTIVES: This study examined the impact of early patient response on treatment utilization and substance use among pregnant participants enrolled in substance use disorder (SUD) treatment. METHODS: Treatment responders (TRs) and treatment nonresponders (TNRs) were compared on pretreatment and treatment measures. Regression models predicted treatment utilization and substance use. RESULTS: TR participants attended more treatment and had lower rates of substance use relative to TNR participants. Regression models for treatment utilization and substance use were significant. Maternal estimated gestational age (EGA) and baseline cocaine use were negatively associated with treatment attendance. Medication-assisted treatment, early treatment response, and baseline SUD treatment were positively associated with treatment attendance. Maternal EGA was negatively associated with counseling attendance; early treatment response was positively associated with counseling attendance. Predictors of any substance use at 1 month were maternal education, EGA, early treatment nonresponse, and baseline cocaine use. The single predictor of any substance use at 2 months was early treatment nonresponse. Predictors of opioid use at 1 month were maternal education, EGA, early treatment nonresponse, and baseline SUD treatment. Predictors of opioid use at 2 months were early treatment nonresponse, and baseline cocaine and marijuana use. Predictors of cocaine use at 1 month were early treatment nonresponse, baseline cocaine use, and baseline SUD treatment. Predictors of cocaine use at 2 months were early treatment nonresponse and baseline cocaine use. CONCLUSIONS: Early treatment response predicts more favorable maternal treatment utilization and substance use outcomes. Treatment providers should implement interventions to maximize patient early response to treatment.
Topic(s):
Opioids & Substance Use
See topic collection
, Healthcare Disparities
See topic collection
9860
The Impact of Integrated Psychological Services in a Safety Net Primary Care Clinic on Medical Utilization
Type: Journal Article
Year: 2017
Publication Place: United States
Topic(s):
Financing & Sustainability
See topic collection
, Healthcare Disparities
See topic collection
Reference Links:
View the DOI record for The Impact of Integrated Psychological Services in a Safety Net Primary Care Clinic on Medical Utilization
View DOI Record
View the PubMed citation for The Impact of Integrated Psychological Services in a Safety Net Primary Care Clinic on Medical Utilization